Meeting
2023 ASCO Annual Meeting
Exploring HER2-low disease: Does it impact breast cancer survival?
Authors
Assumpció López-Paradís
Medical Oncology Department, Catalan Institute of Oncology (ICO)-Badalona, B-ARGO (Badalona Applied Research Group in Oncology) and IGTP (Health Research Institute Germans Trias i Pujol), Universitat Autònoma de Barcelona, 08916, Badalona, Spain, Barcelona, Barcelona, Spain
Assumpció López-Paradís , Anna Pous , Adrià Bernat-Peguera , Vanesa Quiroga , Beatriz Cirauqui , Eudald Felip , Milana Bergamino Jr., Angelica Ferrando-Diez Jr., Marga Romeo , Iris Teruel , Anna Martínez-Cardús , Mireia Margelí
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 577)
DOI
10.1200/JCO.2023.41.16_suppl.577
Abstract #
577
Poster Bd #
407
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
HER2-low breast cancer brain metastases: Incidence and treatment implications.
First Author: Rania Chehade
First Author: Sarah V. Colonna
Poster
2023 ASCO Annual Meeting
Survival outcomes of young patients under 40 with breast cancer in Asian countries according to subtype: An international multicenter cohort study.
First Author: Jinyong Kim
Poster
2022 ASCO Annual Meeting
Does race influence long-term outcomes after neoadjuvant chemotherapy in breast cancer: A National Cancer Database analysis.
First Author: Arya Mariam Roy